Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
Clinical trial NCT01641107 · COMPLETED
Trial details
- NCT number
- NCT01641107
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-04
- Primary completion
- 2020-04-24
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.